Mayo Clinic Laboratory and pathology research roundup: October 19
Share this:
The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.
Featured Abstract
Autopsy validation of progressive supranuclear palsy-predominant speech/language disorder criteria.
Progressive supranuclear palsy (PSP) may present as a speech/language disorder (PSP-SL). Thirty-four prospectively recruited patient with s.o. PSP-SL completed comprehensive speech/language and neurological assessments longitudinally, died, and underwent autopsy. Via PubMed
Published to PubMed This Week
- High-oxygen-affinity hemoglobinopathy-associated erythrocytosis: clinical outcomes and impact of therapy in 41 cases.
American Journal of Hemotology - Neurofascin-155 immunoglobulin subtypes: Clinicopathologic associations and neurologic outcomes.
Neurology - Autoimmune encephalitis post-SARS-CoV-2 infection: Case frequency, findings, and outcomes.
Neurology - Diagnostic value of 16S ribosomal RNA gene polymerase chain reaction/sanger sequencing in clinical practice.
Clinical Infectious Diseases - T2* reduction in patients with acute post-traumatic headache.
Cephalalgia - Quinacrine has preferential anticancer effects on mesothelioma cells with inactivating NF2 mutations.
Frontiers in Pharmacology - Outcomes of epilepsy surgery in the older population: not too old, not too late.
Journal of Neurosurgery - COVID-19 vaccination and glomerulonephritis.
Kidney International Reports - Amplification of femtograms of bacterial DNA within 3 h using a digital microfluidics platform for MinION sequencing.
ACS Omega - Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms.
Blood Advances
